The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups

  1. Stenzl, A.
  2. Szmulewitz, R.Z.
  3. Petrylak, D.
  4. Holzbeierlein, J.
  5. Villers, A.
  6. Azad, A.
  7. Alcaraz, A.
  8. Alekseev, B.
  9. Iguchi, T.
  10. Shore, N.D.
  11. Gomez-Veiga, F.
  12. Ivanescu, C.
  13. Rosbrook, B.
  14. Ramaswamy, K.
  15. Ganguli, A.
  16. Haas, G.P.
  17. Armstrong, A.J.
Revue:
Prostate

ISSN: 1097-0045,  0270-4137

Année de publication: 2022

Volumen: 82

Número: 13

Pages: 1237-1247

Type: Article

DOI: 10.1002/PROS.24396 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus